{
  "id": "PK_PGP_INDUC_DIGOXIN",
  "name": "P-gp induction can decrease exposure of P-gp substrates",
  "domain": "PK",
  "severity": "major",
  "rule_class": "adjust_monitor",
  "tags": ["exposure_decrease"],
  "scenario": {
    "classification": "reference",
    "index_drug": "digoxin",
    "confidence": "medium",
    "notes": "Reference P-gp induction interaction involving a narrow therapeutic index substrate."
  },

  "actions": [
    "Use caution when combining strong P-gp inducers with narrow-TI substrates.",
    "Monitor for reduced effect (and levels when applicable) and adjust therapy as clinically appropriate.",
    "Recognize induction onset and offset are delayed (not immediate)."
  ],
  "logic": {
    "transporter": {
      "family": "ABCB1",
      "A_role": "substrate",
      "B_role": "inducer",
      "B_strength": "strong"
    },
    "A_ti": "narrow",
    "rationale": [
      "{B_name} induces P-gp, increasing efflux of {A_name}.",
      "Reduced exposure may be clinically important for narrow-TI drugs."
    ]
  },
  "explanation_template": "{B_name} is a strong P-gp inducer and {A_name} is a P-gp substrate with a narrow therapeutic index. This can decrease systemic exposure and reduce effect.",
  "references": [
    {
      "source": "Educational note",
      "citation": "Transporter induction + narrow therapeutic index can be clinically meaningful even if magnitude varies."
    }
  ]
}
